Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lale Tokgozoglu

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
Journal of Cardiovascular Computed Tomography|May 25, 2015
Periatrial epicardial adipose tissue thickness is an independent predictor of atrial fibrillation recurrence after cryoballoon-based pulmonary vein isolationDuygu Kocyigit, Kadri Murat Gurses, Muhammed Ulvi Yalcin, et al.
JAMA Cardiology|November 9, 2017
Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical TrialRobert P Giugliano, Anthony Keech, Sabina A Murphy, et al.
Atherosclerosis|May 22, 2023
Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish National DatabaseAlper Sonmez, Ibrahim Demirci, Cem Haymana, et al.
Journal of the American Heart Association|July 16, 2015
Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)Björn Redfors, Oskar Angerås, Truls Råmunddal, et al.
Journal of Cardiovascular Electrophysiology|February 17, 2015
The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural RemodelingMuhammed U Yalcin, Kadri M Gurses, Duygu Kocyigit, et al.
Journal of Clinical Lipidology|September 17, 2024
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias-A report from the European Society of Cardiology Cardiovascular Round TableFrançois Mach, Frank L J Visseren, Nilo B Cater, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|October 31, 2013
[Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary], Scott M Grundy, Hidenori Arai, et al.
Circulation|November 15, 2017
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)Marc P Bonaca, Patrice Nault, Robert P Giugliano, et al.
Journal of Clinical Medicine|September 9, 2023
Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future DirectionsFrancesco Perone, Marco Bernardi, Alban Redheuil, et al.
Atherosclerosis|September 6, 2016
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR), Alberico L Catapano, Ian Graham, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Journal of Cardiovascular Computed Tomography|May 25, 2015
Periatrial epicardial adipose tissue thickness is an independent predictor of atrial fibrillation recurrence after cryoballoon-based pulmonary vein isolationDuygu Kocyigit, Kadri Murat Gurses, Muhammed Ulvi Yalcin, et al.
JAMA Cardiology|November 9, 2017
Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical TrialRobert P Giugliano, Anthony Keech, Sabina A Murphy, et al.
Atherosclerosis|May 22, 2023
Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish National DatabaseAlper Sonmez, Ibrahim Demirci, Cem Haymana, et al.
Journal of the American Heart Association|July 16, 2015
Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)Björn Redfors, Oskar Angerås, Truls Råmunddal, et al.
Journal of Cardiovascular Electrophysiology|February 17, 2015
The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural RemodelingMuhammed U Yalcin, Kadri M Gurses, Duygu Kocyigit, et al.
Journal of Clinical Lipidology|September 17, 2024
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias-A report from the European Society of Cardiology Cardiovascular Round TableFrançois Mach, Frank L J Visseren, Nilo B Cater, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|October 31, 2013
[Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary], Scott M Grundy, Hidenori Arai, et al.
Circulation|November 15, 2017
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)Marc P Bonaca, Patrice Nault, Robert P Giugliano, et al.
Journal of Clinical Medicine|September 9, 2023
Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future DirectionsFrancesco Perone, Marco Bernardi, Alban Redheuil, et al.
Atherosclerosis|September 6, 2016
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR), Alberico L Catapano, Ian Graham, et al.
Pageof 15